Combination drug therapy
A study published in the journal Medicina-buenos Aires has presented real-world data on the efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treating HIV/AIDS patients in Argentina. The research, conducted by a team of Argentine scientists, aimed to describe the safety, persistence, and virologic suppression (VS) rates
Combination drug therapy
A study published in the journal Medicina-buenos Aires has presented real-world data on the efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treating HIV/AIDS patients in Argentina. The research, conducted by a team of Argentine scientists, aimed to describe the safety, persistence, and virologic suppression (VS) rates
Cancer research
Scientists at The Institute of Cancer Research in London have made a breakthrough discovery in treating advanced prostate cancer. They have found that a combination of two targeted drugs could slow down tumour growth and kill cancer cells in up to two-fifths of patients with this type of cancer. The
Cancer research
Scientists at The Institute of Cancer Research in London have made a breakthrough discovery in treating advanced prostate cancer. They have found that a combination of two targeted drugs could slow down tumour growth and kill cancer cells in up to two-fifths of patients with this type of cancer. The
Combination drug therapy
Postmenopausal women with overweight or obesity achieved greater weight loss when using tirzepatide in combination with menopause hormone therapy compared to those using tirzepatide alone. A recent study presented at the Endocrine Society's annual meeting found that the combined treatment resulted in a 17% total body weight loss
